Open Access

Unleashing the full potential of SGLT2 inhibition in heart failure: optimizing patient benefit in clinical practice

Event: Heart Failure 2021 Online Congress
Topic: Heart Failure
Session type: Satellite Symposium
Sponsored by Charité Berlin - Supported by an unrestricted educational grant from Boehringer Ingelheim
Date: 29 June 2021
Time: 17:45 - 18:30

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

Welcome and introduction.

Speaker: Professor I. Pina (Philadelphia, US)
Thumbnail

Optimizing treatment initiation: time matters.

Speaker: Professor J. Butler (Jackson, US)
Speaker: Doctor M. Packer (Dallas, US)
Thumbnail

Optimizing SGLT2 inhibition: recent data.

Speaker: Professor S. Anker (Berlin, DE)
Speaker: Professor A. Coats (Coventry, GB)
Thumbnail

Conclusion.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Thumbnail

6 speakers from this session

Professor Ileana Pina

Thomas Jefferson University, Philadelphia (United States of America)
22 presentations
2 followers

Professor Javed Butler

The University of Mississippi Medical Center, Jackson (United States of America)
71 presentations
5 followers

Doctor Milton Packer

Baylor University Medical Center, Dallas (United States of America)
33 presentations
3 followers

Professor Stefan Anker

Charite Universitatsmedizin Berlin, Berlin (Germany)
116 presentations
4 followers

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
96 presentations
12 followers

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
70 presentations
1 follower

Related content

ESC Premium Access

Personalized Approaches to antiplatelet treatment in ACS-PCI patients

3 December 2021

This platform is supported by

logo Novo Nordisk